Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRQoL and Resource Utilization in NicVAX Phase 3 Studies
NCT01178346Phase 3Completed
- Sponsor
- Nabi Biopharmaceuticals
- Start
- Jul 2010
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of NicVAX in nicotine dependence, sponsored by Nabi Biopharmaceuticals. Started Jul 2010; status: completed.
02
Drugs
NicVAX
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01178346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178346.